A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

BACKGROUND: Pomaglumetad methionil (LY2140023 monohydrate) is a potent and highly selective agonist for the metabotropic glutamate mGluR2 and mGluR3 receptors. We present results of a pivotal clinical study H8Y-MC-HBBM assessing the efficacy of LY2140023 in improving symptoms as a monotherapy in pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Psychiatry
Main Authors: Downing, AnnCatherine M, Kinon, Bruce J, Millen, Brian A, Zhang, Lu, Liu, Lin, Morozova, Margarita A, Brenner, Ronald, Rayle, Tami Jo, Nisenbaum, Laura, Zhao, Fangyi, Gomez, Juan Carlos
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4276262/
https://ncbi.nlm.nih.gov/pubmed/25539791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-014-0351-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados